Indication:

For:

• Imatinib is a targeted tyrosine kinase inhibitor primarily used to treat various blood cancers and specific solid tumors. Its core indication revolves around cancers driven by abnormal cell growth proteins, most notably the Philadelphia chromosome-positive (Ph+) mutation.

Supplied as:

Tablet:

• • 800mg,400mg (10’s)

Disclaimer:

Please consult your doctor before taking any medicine. To be sold only on prescription.